By Brazil Stock Guide – Qualicorp S.A. (B3: QUAL3) posted a loss in the fourth quarter of 2025, capping a year marked by portfolio contraction and asset disposals. The Brazilian administrator of collective health plans reported full-year adjusted net income of R$ 41.8 million (US$ 8.4 million), down 50.5% from 2024. The fourth quarter concentrated non-recurring effects and strategic divestments.
In 2025, net revenue totaled R$ 1.458 billion (US$ 292 million), a 7.7% decline year over year. Adjusted EBITDA reached R$ 588.6 million (US$ 118 million), down 13.5%, with a 40.4% margin versus 43.0% in 2024. Judicial contingencies rose 39.6%, reflecting higher provisions tied to unilateral contract cancellations in prior periods. Net debt closed December at R$ 853.6 million (US$ 171 million), equivalent to 1.45 times EBITDA.
In the fourth quarter, Qualicorp finalized the sale of its Corporate and Gama units. The transactions generated a non-recurring cash inflow of R$ 51.7 million and an outflow of R$ 27.2 million related to the Gama divestment. The company also issued R$ 400 million (US$ 80 million) in debentures to extend debt maturities.
Client Base Contracts
Qualicorp’s total client base fell 14.6% in 2025 to 827,700 lives. The core collective adhesion portfolio declined 16.5% to 726,400 lives. By contrast, the small and mid-sized enterprise (SME) segment expanded 4.9% to 101,300 lives. The two-digit contraction in adhesion plans largely explains the revenue decline.
Brazil’s private health administration market faces high interest rates, tighter household income and rising litigation. While insurers pursue premium adjustments, administrators must manage cancellations and retention.
The fourth quarter signals structural repositioning rather than expansion. Qualicorp is prioritizing cash preservation and debt management over scale. The key question for 2026 is whether the company can stabilize its client base and rebuild recurring profitability without relying on one-off gains.
Leave a Reply